A citation-based method for searching scientific literature

Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
Times Cited: 289







List of co-cited articles
576 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer.
Mark H Ebell, MaryBeth B Culp, Taylor J Radke. Am J Prev Med 2016
64
1

Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.
David M Gershenson, Diane C Bodurka, Robert L Coleman, Karen H Lu, Anais Malpica, Charlotte C Sun. J Clin Oncol 2017
90
1

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.
Alon D Altman, Gregg S Nelson, Prafull Ghatage, John B McIntyre, David Capper, Pamela Chu, Jill G Nation, Anthony N Karnezis, Guangming Han, Steve E Kalloger,[...]. Mod Pathol 2013
31
3

Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities.
L Chuang, J Berek, T Randall, M McCormack, K Schmeler, R Manchanda, T Rebbeck, C J Jeng, D Pyle, M Quinn,[...]. Gynecol Oncol Rep 2018
3
33

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer.
Shinichi Komiyama, Hidetaka Katabuchi, Mikio Mikami, Satoru Nagase, Aikou Okamoto, Kiyoshi Ito, Kenichiro Morishige, Nao Suzuki, Masanori Kaneuchi, Nobuo Yaegashi,[...]. Int J Clin Oncol 2016
21
4

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. J Clin Oncol 2016
176
1

Global trends and predictions in ovarian cancer mortality.
M Malvezzi, G Carioli, T Rodriguez, E Negri, C La Vecchia. Ann Oncol 2016
65
1

Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Robert A Burger, Mark F Brady, Michael A Bookman, Gini F Fleming, Bradley J Monk, Helen Huang, Robert S Mannel, Howard D Homesley, Jeffrey Fowler, Benjamin E Greer,[...]. N Engl J Med 2011
1


Is comprehensive surgical staging needed for thorough evaluation of early-stage ovarian carcinoma?
Arlene E Garcia-Soto, Todd Boren, Shana N Wingo, Thomas Heffernen, David S Miller. Am J Obstet Gynecol 2012
19
5

Global ovarian cancer health disparities.
Ganna Chornokur, Ernest K Amankwah, Joellen M Schildkraut, Catherine M Phelan. Gynecol Oncol 2013
78
1

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, Barbara M Norquist, Elizabeth M Swisher, Mark F Brady, Michael A Bookman, Gini F Fleming, Helen Huang, Howard D Homesley,[...]. J Clin Oncol 2019
98
1

Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
Benjamin O Anderson, Roman Shyyan, Alexandru Eniu, Robert A Smith, Cheng-Har Yip, Nuran Senel Bese, Louis W C Chow, Shahla Masood, Scott D Ramsey, Robert W Carlson. Breast J 2006
207
1

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.
William P Tew, Christina Lacchetti, Annie Ellis, Kathleen Maxian, Susana Banerjee, Michael Bookman, Monica Brown Jones, Jung-Min Lee, Stéphanie Lheureux, Joyce F Liu,[...]. J Clin Oncol 2020
18
5


Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Russell Vang, Douglas A Levine, Robert A Soslow, Charles Zaloudek, Ie-Ming Shih, Robert J Kurman. Int J Gynecol Pathol 2016
76
1

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.
Philipp Harter, Jalid Sehouli, Domenica Lorusso, Alexander Reuss, Ignace Vergote, Christian Marth, Jae-Weon Kim, Francesco Raspagliesi, Björn Lampe, Giovanni Aletti,[...]. N Engl J Med 2019
132
1

American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology.
D Andrew Loblaw, Ann Alexis Prestrud, Mark R Somerfield, Thomas K Oliver, Melissa C Brouwers, Robert K Nam, Gary H Lyman, Ethan Basch. J Clin Oncol 2012
100
1

British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice.
Christina Fotopoulou, Marcia Hall, Derek Cruickshank, Hani Gabra, Raji Ganesan, Cathy Hughes, Sean Kehoe, Jonathan Ledermann, Jo Morrison, Raj Naik,[...]. Eur J Obstet Gynecol Reprod Biol 2017
21
4

Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline.
Timothy Gilligan, Nessa Coyle, Richard M Frankel, Donna L Berry, Kari Bohlke, Ronald M Epstein, Esme Finlay, Vicki A Jackson, Christopher S Lathan, Charles L Loprinzi,[...]. J Clin Oncol 2017
165
1

A phase 3 trial of bevacizumab in ovarian cancer.
Timothy J Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder,[...]. N Engl J Med 2011
1

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. Gynecol Oncol 2016
121
1

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Amit M Oza, Adrian D Cook, Jacobus Pfisterer, Andrew Embleton, Jonathan A Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes,[...]. Lancet Oncol 2015
350
1

Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline.
E Gabriela Chiorean, Govind Nandakumar, Temidayo Fadelu, Sarah Temin, Ashley Efrain Alarcon-Rozas, Suyapa Bejarano, Adina-Emilia Croitoru, Surbhi Grover, Pritesh V Lohar, Andrew Odhiambo,[...]. JCO Glob Oncol 2020
18
5

Sample Tracking Using Unique Sequence Controls.
Richard A Moore, Thomas Zeng, T Roderick Docking, Ian Bosdet, Yaron S Butterfield, Sarah Munro, Irene Li, Lucas Swanson, Elizabeth R Starks, Kane Tse,[...]. J Mol Diagn 2020
2
50

Advances in the use of PARP inhibitor therapy for breast cancer.
Kelly E McCann, Sara A Hurvitz. Drugs Context 2018
54
1

Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data.
Valentina Boeva, Tatiana Popova, Maxime Lienard, Sebastien Toffoli, Maud Kamal, Christophe Le Tourneau, David Gentien, Nicolas Servant, Pierre Gestraud, Thomas Rio Frio,[...]. Bioinformatics 2014
70
1

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
1

Standard mutation nomenclature in molecular diagnostics: practical and educational challenges.
Shuji Ogino, Margaret L Gulley, Johan T den Dunnen, Robert B Wilson. J Mol Diagn 2007
94
1

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.
Kara N Maxwell, Bradley Wubbenhorst, Brandon M Wenz, Daniel De Sloover, John Pluta, Lyndsey Emery, Amanda Barrett, Adam A Kraya, Ioannis N Anastopoulos, Shun Yu,[...]. Nat Commun 2017
95
1

Counting absolute numbers of molecules using unique molecular identifiers.
Teemu Kivioja, Anna Vähärautio, Kasper Karlsson, Martin Bonke, Martin Enge, Sten Linnarsson, Jussi Taipale. Nat Methods 2011
478
1


Molecular targeted therapy: Treating cancer with specificity.
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon. Eur J Pharmacol 2018
148
1

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Daniel G Coit, John A Thompson, Mark R Albertini, Christopher Barker, William E Carson, Carlo Contreras, Gregory A Daniels, Dominick DiMaio, Ryan C Fields, Martin D Fleming,[...]. J Natl Compr Canc Netw 2019
141
1

Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays.
Radoje Drmanac, Andrew B Sparks, Matthew J Callow, Aaron L Halpern, Norman L Burns, Bahram G Kermani, Paolo Carnevali, Igor Nazarenko, Geoffrey B Nilsen, George Yeung,[...]. Science 2010
742
1


VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Daniel C Koboldt, Qunyuan Zhang, David E Larson, Dong Shen, Michael D McLellan, Ling Lin, Christopher A Miller, Elaine R Mardis, Li Ding, Richard K Wilson. Genome Res 2012
1

Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.
Aung Ko Win, Jeanette C Reece, James G Dowty, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Melissa C Southey, Joanne P Young, Sean P Cleary, Hyeja Kim,[...]. Int J Cancer 2016
47
2

fastp: an ultra-fast all-in-one FASTQ preprocessor.
Shifu Chen, Yanqing Zhou, Yaru Chen, Jia Gu. Bioinformatics 2018
1

Additional germline findings from a tumor profiling program.
Neda Stjepanovic, Tracy L Stockley, Philippe L Bedard, Jeanna M McCuaig, Melyssa Aronson, Spring Holter, Kara Semotiuk, Natasha B Leighl, Raymond Jang, Monika K Krzyzanowska,[...]. BMC Med Genomics 2018
7
14

Analysis of TP53 mutation status in human cancer cell lines: a reassessment.
Bernard Leroy, Luc Girard, Antoinette Hollestelle, John D Minna, Adi F Gazdar, Thierry Soussi. Hum Mutat 2014
98
1

Anchored multiplex PCR for targeted next-generation sequencing.
Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D Lynch, Juxiang Chen, Hayley E Robinson, Hyo Sup Shim, Juliann Chmielecki,[...]. Nat Med 2014
454
1

Integrative genomics viewer.
James T Robinson, Helga Thorvaldsdóttir, Wendy Winckler, Mitchell Guttman, Eric S Lander, Gad Getz, Jill P Mesirov. Nat Biotechnol 2011
1

Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.
Colin C Pritchard, Stephen J Salipante, Karen Koehler, Christina Smith, Sheena Scroggins, Brent Wood, David Wu, Ming K Lee, Suzanne Dintzis, Andrew Adey,[...]. J Mol Diagn 2014
183
1

The Sequence Alignment/Map format and SAMtools.
Heng Li, Bob Handsaker, Alec Wysoker, Tim Fennell, Jue Ruan, Nils Homer, Gabor Marth, Goncalo Abecasis, Richard Durbin. Bioinformatics 2009
1

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
Thomas W Kensler, Avrum Spira, Judy E Garber, Eva Szabo, J Jack Lee, Zigang Dong, Andrew J Dannenberg, William N Hait, Elizabeth Blackburn, Nancy E Davidson,[...]. Cancer Prev Res (Phila) 2016
83
1

Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030.
Anne S Quante, Chang Ming, Miriam Rottmann, Jutta Engel, Stefan Boeck, Volker Heinemann, Christoph Benedikt Westphalen, Konstantin Strauch. Cancer Med 2016
68
1

Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Mandy L Ballinger, David L Goode, Isabelle Ray-Coquard, Paul A James, Gillian Mitchell, Eveline Niedermayr, Ajay Puri, Joshua D Schiffman, Gillian S Dite, Arcadi Cipponi,[...]. Lancet Oncol 2016
108
1

How I approach hereditary cancer predisposition in a child with cancer.
Michaela Kuhlen, Dagmar Wieczorek, Reiner Siebert, Michael C Frühwald. Pediatr Blood Cancer 2019
3
33

Cancer incidence and survival in European adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project.
C A Stiller, E Desandes, S E Danon, I Izarzugaza, A Ratiu, Z Vassileva-Valerianova, E Steliarova-Foucher. Eur J Cancer 2006
125
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.